Astaxanthin Regulation: Changes and Adjustments

Amendments to the Terms of Use for Astaxanthin-Rich Oleoresin: Analysis of European Commission Regulation (EU) 2023/2852 On December 21, 2023, the Official Journal of the European Union published Commission Implementing Regulation (EU) 2023/2852, dated December 20, 2023, which corrects Commission Implementing Regulation (EU) 2023/1581. The latter regulation amends Implementing Regulation (EU) 2017/2470 regarding the conditions…

Effects of Nigella Sativa in Diabetic Neuropathy

Clinical Study: Topical Benefits of Nigella Sativa in Diabetic Neuropathy Compared to Synthetic Drugs Diabetic neuropathy is one of the most common complications of diabetes. Synthetic drugs available on the market have side effects and limitations for diabetic patients, the majority of whom are elderly. In this context, based on Persian medicinal sources, it has…

GFI certifies a new Medical Device in Macedonia

Treatment for Vulvovaginal Mycotic Infections: FarmaImpresa Group certifies a new Medical Device in Macedonia We have completed the registration with the competent authorities in Macedonia for a Class I medical device, designed for the treatment of vulvovaginal mycotic infections. The medical device is formulated as a vaginal suppository based on hyaluronic acid, boric acid, and…

Female Asthma: Hormones and Phytoestrogens

The Role of Sexual Hormones and Potential Phytoestrogen-Based Therapies in Female Asthma: Perspectives and Challenges The scientific literature extensively illustrates asthma as an inflammatory disease. Symptoms in asthmatic women appear linked to their sexual hormonal state (i.e., perimenopausal, pregnancy, menopause). Studies establish worsened pulmonary conditions in women, reflected in severity, exacerbation rates, hospitalizations, and mortality.…